Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | CDK6 |
Upstream (Parents) |
---|
(<<) ARL4C → CDK6 |
(<<) BMPR2 → CDK6 |
(<<) CASKIN1 → CDK6 |
(<<) CMTM7 → CDK6 |
(<<) COIL → CDK6 |
(<<) DYNC1LI2 → CDK6 |
(<<) EML4 → CDK6 |
(<<) FZD7 → CDK6 |
(<<) HDAC11 → CDK6 |
(<<) KPNA1 → CDK6 |
(<<) KRAS → CDK6 |
(<<) MAP3K5 → CDK6 |
(<<) NCOA3 → CDK6 |
(<<) NFAT5 → CDK6 |
(<<) NRIP1 → CDK6 |
(<<) PDPK1 → CDK6 |
(<<) RAB5C → CDK6 |
(<<) SLC20A1 → CDK6 |
Downstream (Children) |
---|
CDK6 → ADCY6 (>>) |
CDK6 → ADORA2B (>>) |
CDK6 → AKT3 (>>) |
CDK6 → ANKRD57 (>>) |
CDK6 → ASNS (>>) |
CDK6 → BDH1 (>>) |
CDK6 → CAMKK2 (>>) |
CDK6 → CCND1 (>>) |
CDK6 → CDC42EP5 (>>) |
CDK6 → CDH24 (>>) |
CDK6 → CHODL (>>) |
CDK6 → DNAJA4 (>>) |
CDK6 → EGFR (>>) |
CDK6 → ENC1 (>>) |
CDK6 → EPHA4 (>>) |
CDK6 → FGFBP1 (>>) |
CDK6 → FOXC2 (>>) |
CDK6 → FOXQ1 (>>) |
CDK6 → FZD1 (>>) |
CDK6 → GDF15 (>>) |
CDK6 → GNAI1 (>>) |
CDK6 → GSTZ1 (>>) |
CDK6 → HEY1 (>>) |
CDK6 → HSPA4 (>>) |
CDK6 → ITPR2 (>>) |
CDK6 → JAG1 (>>) |
CDK6 → JAK2 (>>) |
CDK6 → KRT14 (>>) |
CDK6 → KRT6B (>>) |
CDK6 → LRP6 (>>) |
CDK6 → NEUROG1 (>>) |
CDK6 → NFKBIZ (>>) |
CDK6 → NRSN2 (>>) |
CDK6 → OSBPL8 (>>) |
CDK6 → PODXL (>>) |
CDK6 → PRKCI (>>) |
CDK6 → RELL2 (>>) |
CDK6 → RXRG (>>) |
CDK6 → S100A2 (>>) |
CDK6 → SHFM1 (>>) |
CDK6 → SLC6A14 (>>) |
CDK6 → SMARCC2 (>>) |
CDK6 → SMOX (>>) |
CDK6 → SOS1 (>>) |
CDK6 → SYK (>>) |
CDK6 → SYNJ2 (>>) |
CDK6 → UBE2D3 (>>) |
CDK6 → WNT5B (>>) |
CDK6 → ZNF224 (>>) |
CDK6 → ZNF467 (>>) |